261 related articles for article (PubMed ID: 15370691)
21. Effect of cisapride on oesophageal motility and duodenogastro-oesophageal reflux in patients with Barrett's oesophagus.
Smythe A; Bird NC; Troy GP; Globe J; Johnson AG
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1149-53. PubMed ID: 9471019
[TBL] [Abstract][Full Text] [Related]
22. Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults.
Chak A; Lee T; Kinnard MF; Brock W; Faulx A; Willis J; Cooper GS; Sivak MV; Goddard KA
Gut; 2002 Sep; 51(3):323-8. PubMed ID: 12171951
[TBL] [Abstract][Full Text] [Related]
23. Young patients with Barrett's oesophagus experience less reflux complaints.
Loffeld RJ
Digestion; 2001; 64(3):151-4. PubMed ID: 11786662
[TBL] [Abstract][Full Text] [Related]
24. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
[TBL] [Abstract][Full Text] [Related]
25. Leptin and the risk of Barrett's oesophagus.
Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
[TBL] [Abstract][Full Text] [Related]
26. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
27. Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study.
Filiberti RA; Fontana V; De Ceglie A; Blanchi S; Grossi E; Della Casa D; Lacchin T; De Matthaeis M; Ignomirelli O; Cappiello R; Rosa A; Foti M; Laterza F; D'Onofrio V; Iaquinto G; Conio M
Br J Nutr; 2017 Apr; 117(8):1151-1161. PubMed ID: 28478792
[TBL] [Abstract][Full Text] [Related]
28. Gastro-oesophageal reflux: the disease of the millennium.
Navaratnam RM; Winslet MC
Hosp Med; 1998 Aug; 59(8):646-9. PubMed ID: 9829061
[TBL] [Abstract][Full Text] [Related]
29. The changing spectrum of gastroesophageal reflux disease.
Todd JA; Johnston DA; Dillon JF
Eur J Cancer Prev; 2002 Jun; 11(3):215-9. PubMed ID: 12131654
[TBL] [Abstract][Full Text] [Related]
30. Corpus gastritis in patients with endoscopic diagnosis of reflux oesophagitis and Barrett's oesophagus.
Laheij RJ; Van Rossum LG; De Boer WA; Jansen JB
Aliment Pharmacol Ther; 2002 May; 16(5):887-91. PubMed ID: 11966496
[TBL] [Abstract][Full Text] [Related]
31. Does Barrett's oesophagus develop over time in patients with chronic gastro-oesophageal reflux disease?
Stoltey J; Reeba H; Ullah N; Sabhaie P; Gerson L
Aliment Pharmacol Ther; 2007 Jan; 25(1):83-91. PubMed ID: 17229223
[TBL] [Abstract][Full Text] [Related]
32. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress has a role in malignant transformation in Barrett's oesophagus.
Sihvo EI; Salminen JT; Rantanen TK; Rämö OJ; Ahotupa M; Färkkilä M; Auvinen MI; Salo JA
Int J Cancer; 2002 Dec; 102(6):551-5. PubMed ID: 12447994
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett's oesophagus.
Zentilin P; Conio M; Mele MR; Mansi C; Pandolfo N; Dulbecco P; Gambaro C; Tessieri L; Iiritano E; Bilardi C; Biagini R; Vigneri S; Savarino V
Aliment Pharmacol Ther; 2002 May; 16(5):893-8. PubMed ID: 11966497
[TBL] [Abstract][Full Text] [Related]
35. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only--what is the clinical significance?
Meining A; Ott R; Becker I; Hahn S; Mühlen J; Werner M; Höfler H; Classen M; Heldwein W; Rösch T
Gut; 2004 Oct; 53(10):1402-7. PubMed ID: 15361485
[TBL] [Abstract][Full Text] [Related]
36. Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
Vaughan TL; Dong LM; Blount PL; Ayub K; Odze RD; Sanchez CA; Rabinovitch PS; Reid BJ
Lancet Oncol; 2005 Dec; 6(12):945-52. PubMed ID: 16321762
[TBL] [Abstract][Full Text] [Related]
37. Mortality and cardiovascular diseases risk in patients with Barrett's oesophagus: a population-based nationwide cohort study.
Erichsen R; Horvath-Puho E; Lund JL; Dellon ES; Shaheen NJ; Pedersen L; Davey Smith G; Sørensen HT
Aliment Pharmacol Ther; 2017 Apr; 45(7):973-982. PubMed ID: 28139003
[TBL] [Abstract][Full Text] [Related]
38. Review: Barrett's oesophagus in Taiwan.
Chen PH
J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
[TBL] [Abstract][Full Text] [Related]
39. Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.
Lundell L
Digestion; 1992; 51 Suppl 1():49-58. PubMed ID: 1356869
[TBL] [Abstract][Full Text] [Related]
40. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
